Serial Number
97472478
Owner
Bristol-Myers Squibb CompanyAttorney
Marilyn F. KellyFiling Date
Jun 23, 2022
ZILRYENZ Trademark
Serial Number: 97472478
Trademark Classes
Owner Contact Info
Route 206 & Province Line Road
Princeton, NJ 08543
Entity Type: 03
Legal Representation
Correspondence Address
Marilyn F. Kelly BRISTOL-MYERS SQUIBB COMPANY
P.O. BOX 4000
TRADEMARK DEPT., MAILSTOP D.4243
PRINCETON, NJ 08648-4000
United States
Trademark Details
Filing Date
June 23, 2022
Registration Date
Not Registered
Published for Opposition
April 4, 2023
Goods & Services
Pharmaceutical preparations for human use for the treatment and prevention of obesity, incontinence, cardiovascular diseases, central nervous system diseases and disorders, metabolic disorders, stroke, cancer, inflammation and inflammatory diseases, respiratory and infectious diseases, auto-immune diseases, solid organ transplant rejection, beta thalassemia and myelodysplastic syndromes, myeloproliferative diseases, myelofibrosis, leukemia, lymphoma, multiple myeloma, autoinflammatory disease, blood disease, tumors, multiple sclerosis, ulcerative colitis, arthritis, and musculoskeletal and skin diseases; Pharmaceutical preparations for human use, namely, antibiotics, anti-fungals, anti-virals, immunosuppressants, pharmaceutical antibodies, immunotherapies for the treatment of cancer, cytokine inhibitory drugs; Pharmaceutical preparations for human use that modulate the immune system; Pharmaceutical and biological preparations for human use for immunotherapy, namely T Cell therapy; Pharmaceutical preparations for human use, namely, stem cells for medical or clinical use; Pharmaceutical preparations for human use for the treatment or prevention of covid-19, coronavirus disease, and respiratory diseases and disorders; Pharmaceutical preparations for human use, namely, antivirals for treatment or prevention of covid-19, coronavirus disease, and respiratory diseases and disorders; Pharmaceutical preparations for human use, namely, monoclonal antibodies for medical use
